Drugs / parnaparin
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 32 trials · 1 met primary | ||||||
| Phase 3 | NCT02991950 | Jul 2011 → Mar 2015 | infertility disorder | Istituto Clinico Humanitas | Terminated | No outcome recorded Stop: Enrollment |
| Phase 3 | NCT00732927 | Jul 2002 → Jul 2006 | retinal vein occlusion | University of Insubria | Terminated | Met primary Stop: Enrollment |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00362947 Comparator | Aug 2006 → Sep 2010 | thrombophlebitis | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | parnaparin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00732927 ↗ |
| Known as | Parnaparin sodium | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02991950 ↗ |
| Modality | Other / unclassified | “low molecular weight heparin (LMWH)” NCT00362947 ↗ |
| Route | Subcutaneous | “Drug: LMWH parnaparin subcutaneously” NCT00362947 ↗ |